(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of -20.86% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 119.46%.
Rockwell Medical's revenue in 2025 is $87,966,000.On average, 1 Wall Street analysts forecast RMTI's revenue for 2025 to be $2,397,041,106, with the lowest RMTI revenue forecast at $2,397,041,106, and the highest RMTI revenue forecast at $2,397,041,106.
In 2026, RMTI is forecast to generate $2,806,417,992 in revenue, with the lowest revenue forecast at $2,806,417,992 and the highest revenue forecast at $2,806,417,992.